XML 12 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Based Compensation
6 Months Ended
Mar. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-based Compensation [Text Block]
Stock-based Compensation
Stock-Based Benefit Plans
The Company grants stock-based compensation awards under its 2007 Incentive Compensation Plan (the 2007 Plan) which permits the grant of stock options, stock appreciation rights, restricted stock awards, restricted stock units (RSUs), performance shares and performance units. The Company has outstanding grants under prior plans, though no further grants can be made under these prior plans. At March 31, 2012, 1,638,000 shares were available for future grant under the 2007 Plan. Options generally vest ratably over a four-year period with a 6-month or 1-year cliff vest and then vesting ratably over the remaining period. Options granted prior to October 1, 2005 expire ten years after the date of grant; options granted after October 1, 2005 expire seven years after the date of the grant. RSUs generally vest annually over periods ranging from two years to four years based upon continued employment with the Company.
In addition, the Company has an Employee Stock Purchase Plan (ESPP) which permits eligible employees to purchase the Company’s common stock through payroll deductions. As approved by the Board of Directors, effective August 1, 2010, shares under the ESPP will be purchased at a price equal to 85% of the lesser of the fair market value of the Company’s common stock as of the first day or the last day of each six-month offering period. The offering periods under the ESPP commence on approximately February 1 and August 1 of each year. At March 31, 2012, 902,000 shares were available for future issuance under the ESPP.
Stock-Based Compensation
The following table outlines the effects of total stock-based compensation.
 
 
Three Months Ended
March 31,
 
Six Months Ended
March 31,
 
 
2012
 
2011
 
2012
 
2011
 
 
(In thousands)
Stock-based compensation
 
 
 
 
 
 
 
 
Cost of sales
 
$
33

 
$
57

 
$
66

 
$
96

Research and development
 
343

 
282

 
658

 
541

Selling, general and administrative
 
886

 
758

 
1,723

 
1,346

Total stock-based compensation
 
1,262

 
1,097

 
2,447

 
1,983

Tax effect on stock-based compensation
 

 

 

 

Net effect on net income
 
$
1,262

 
$
1,097

 
$
2,447

 
$
1,983


As of March 31, 2012, there was approximately $8.9 million of total unrecognized stock-based compensation expense under the Company’s stock option plans that will be recognized over a weighted-average period of approximately 2.49 years. Future stock option grants will add to this total whereas quarterly amortization and the vesting of the existing stock option grants will reduce this total. In addition, as of March 31, 2012, there was approximately $0.2 million of total unrecognized stock-based compensation expense under the Company’s ESPP that will be recognized over a weighted-average period of approximately 4 months.
 
The Company uses the Black-Scholes option pricing model to estimate the fair value of the options granted and rights to acquire stock granted under the ESPP. The weighted average estimated fair values of stock option grants and rights granted under the ESPP, as well as the weighted average assumptions used in calculating these values during the three and six month periods ended March 31, 2012 and 2011 were based on estimates at the date of grant as follows:
 
 
Three Months Ended
March 31,
 
Six Months Ended
March 31,
 
 
2012
 
2011
 
2012
 
2011
Options
 
 
 
 
 
 
 
 
Weighted-average fair value of grants
 
$
4.79

 
$
4.97

 
$
4.49

 
$
3.86

Expected term in years
 
4.37

 
4.37

 
4.37

 
4.37

Estimated volatility
 
60
%
 
57
%
 
60
%
 
58
%
Risk-free interest rate
 
0.61
%
 
1.76
%
 
0.68
%
 
1.21
%
Dividend yield
 
%
 
%
 
%
 
%
ESPP
 
 
 
 
 
 
 
 
Weighted-average fair value of grants
 
$
2.98

 
$
3.18

 
$
2.98

 
$
3.18

Expected term in years
 
0.50

 
0.50

 
0.50

 
0.50

Estimated volatility
 
52
%
 
53
%
 
52
%
 
53
%
Risk-free interest rate
 
0.07
%
 
0.18
%
 
0.07
%
 
0.18
%
Dividend yield
 
%
 
%
 
%
 
%

The Company issues RSUs from time to time. The estimated fair value of RSU awards is calculated based on the market price of the Company’s common stock on the date of grant. The weighted average grant date fair value of RSUs granted in the three month period ended March 31, 2011 was $10.64 per share and the weighted average grant date fair value of RSUs granted in the six month periods ended March 31, 2012 and 2011, was $9.36 per share and $7.41 per share, respectively.
During the six months ended March 31, 2012, employees purchased a total of 97,000 shares for $0.7 million under the ESPP. During the six months ended March 31, 2011, employees purchased a total of 81,000 shares for $0.6 million under the ESPP.
A summary of the Company’s stock option activity and related information for the six months ended March 31, 2012 follows (number of shares and aggregate intrinsic value are presented in thousands):
 
 
Number of
Shares
 
Weighted-Average
Exercise Price
 
Weighted-Average
Remaining
Contractual Term in Years
 
Aggregate
Intrinsic Value
Outstanding at September 30, 2011
 
4,851

 
$
5.57

 
 
 
 
Granted
 
883

 
$
9.42

 
 
 
 
Exercised
 
(636
)
 
$
5.21

 
 
 
$
3,074

Cancelled/Expired
 
(66
)
 
$
10.79

 
 
 
 
Outstanding at March 31, 2012
 
5,032

 
$
6.22

 
4.41

 
$
24,865

Exercisable at March 31, 2012
 
2,718

 
$
5.23

 
3.36

 
$
16,133

Vested and expected to vest after March 31, 2012
 
4,889

 
$
6.16

 
4.37

 
$
24,436



 
A summary of the Company’s RSU activity and related information for the six months ended March 31, 2012 under the 2007 Plan follows (number of shares and aggregate intrinsic value are presented in thousands):
 
 
Number of
Shares
 
Weighted-Average
Grant Date
Fair Value
 
Aggregate
Intrinsic Value
Outstanding at September 30, 2011
 
382

 
$
7.84

 
 
Granted
 
100

 
$
9.36

 
 
Vested
 
(144
)
 
$
7.64

 
$
1,356

Forfeited
 

 
$

 
 
Outstanding at March 31, 2012
 
338

 
$
8.37

 
$
3,778